Leap Therapeutics Inc (5MC)

Currency in EUR
0.1700
+0.0760(+80.85%)
Closed·
5MC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
5MC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.17000.1700
52 wk Range
0.05004.5400
Key Statistics
Bid/Ask
0.20 / 0.326
Prev. Close
0.17
Open
0.17
Day's Range
0.17-0.17
52 wk Range
0.05-4.54
Volume
-
Average Volume (3m)
1
1-Year Change
-90.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
5MC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Leap Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Leap Therapeutics Inc Company Profile

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Compare 5MC to Peers and Sector

Metrics to compare
5MC
Peers
Sector
Relationship
P/E Ratio
−0.2x−3.7x−0.5x
PEG Ratio
−0.010.010.00
Price/Book
0.6x3.3x2.6x
Price / LTM Sales
-166.2x3.3x
Upside (Analyst Target)
-189.3%45.1%
Fair Value Upside
Unlock0.9%7.4%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.37 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

5MC Income Statement

People Also Watch

0.600
WINT
-11.11%
0.3558
VXRT
-3.84%
2.56
INMB
-6.23%
0.92
KLTO
-4.15%
15.91
SRPT
-3.11%

FAQ

What Stock Exchange Does Leap Therapeutics Inc Trade On?

Leap Therapeutics Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Leap Therapeutics Inc?

The stock symbol for Leap Therapeutics Inc is "5MC."

What Is the Leap Therapeutics Inc Market Cap?

As of today, Leap Therapeutics Inc market cap is 10.95M.

What Is Leap Therapeutics Inc's Earnings Per Share (TTM)?

The Leap Therapeutics Inc EPS (TTM) is -1.69.

From a Technical Analysis Perspective, Is 5MC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Leap Therapeutics Inc Stock Split?

Leap Therapeutics Inc has split 1 times.

How Many Employees Does Leap Therapeutics Inc Have?

Leap Therapeutics Inc has 26 employees.

What is the current trading status of Leap Therapeutics Inc (5MC)?

As of 04 Aug 2025, Leap Therapeutics Inc (5MC) is trading at a price of 0.17, with a previous close of 0.17. The stock has fluctuated within a day range of 0.17 to 0.17, while its 52-week range spans from 0.05 to 4.54.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.